Effects of Metformin Treatment on Soluble Leptin Receptor Levels in Women with Polycystic Ovary Syndrome

Abstract

The effects of metformin treatment on soluble leptin receptor (sOB-R) levels in women with polycystic ovary syndrome (PCOS) were investigated. This prospective and open-label study was conducted by the Department of Obstetrics & Gynecology at Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, China. Fifty-five women with PCOS and insulin resistance (IR) were treated with metformin for 6 months. According to body mass index (BMI), the patients were divided into two groups: lean PCOS group (BMI <23 kg/m², n=34) and overweight or obese PCOS group (BMI ≥23 kg/m², n=21). Before and after treatment, serum luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone (T), androstenedione (A), dehydroepiandrosterone sulfate (DHEAS), insulin and sOB-R levels were determined. Thirty-one BMI-matched ovulatory women served as controls. The results showed: (1) The Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), androgen levels and hirsutism scores were higher, and sOB-R levels were lower in PCOS groups than in control group. A subgroup analysis of lean and overweight or obese PCOS patients revealed there was significant difference in sOB-R level between lean PCOS group and overweight or obese PCOS group. There were no significant differences in anthropometric parameters between lean PCOS patients and BMI-matched controls. However, sOB-R level was significantly lower in lean PCOS women than in controls. (2) There was no correlation between sOB-R level and BMI, waist and hip circumference, total testosterone, androstendione, DHEAS, LH or hirsutism scores in PCOS patients, but there was a significant negative correlation between sOB-R and HOMA-IR. (3) After treatment with metformin for 6 months, serum insulin levels decreased, and sOB-R levels increased significantly (P<0.01). It was suggested that considering low sOB-R levels supposedly compensate diminished leptin action, PCOS per se might cause leptin resistance. It is likely that reduction of hyperinsulinemia produced by metformin effectively improves the sOB-R levels in PCOS.

Keywords

polycystic ovary syndrome / metformin / insulin resistance / leptin resistance / soluble leptin receptor

References

[1] RothenbergSS, BeverleyR, BarnardE, et al.. Polycystic ovary syndrome in adolescents. Best Pract Res Clin Obstet Gynaecol, 2018, 48: 103-114

[2] PasqualiR, GambineriA. New perspectives on the definition and management of polycystic ovary syndrome. J Endocrinol Invest, 2018, 41(10): 1123-1135

[3] Behboudi-GandevaniS, Ramezani TehraniF, Rostami DovomM, et al.. Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. Gynecol Endocrinol, 2016, 32(5): 343-353

[4] JeanesYM, ReevesS. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. Nutr Res Rev, 2017, 30(1): 97-105

[5] DavisC, MuddJ, HawkinsM. Neuroprotective effects of leptin in the context of obesity and metabolic disorders. Neurobiol Dis, 2014, 72: 61-71

[6] ZhangY, ChuaSJr. Leptin Function and Regulation. Compr Physiol, 2017, 8(1): 351-369

[7] CuiH, LopezM, RahmouniK. The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol, 2017, 13(6): 338-351

[8] DallelM, SghaierI, FinanRR, et al.. Circulating leptin concentration, LEP gene variants and haplotypes, and polycystic ovary syndrome in Bahraini and Tunisian Arab women. Gene, 2019, 694: 19-25

[9] DaghestaniMH, DaghestaniM, DaghistaniM, et al.. A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS). Lipids Health Dis, 2018, 17(1): 195

[10] SchaabM, KratzschJ. The soluble leptin receptor. Best Pract Res Clin Endocrinol Metab, 2015, 29(5): 661-670

[11] SepilianVP, CrochetJR, NagamaniM. Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens. Fertil Steril, 2006, 85(5): 1441-1447

[12] TuX, YuC, GaoM, et al.. LEPR gene polymorphism and plasma soluble leptin receptor levels are associated with polycystic ovary syndrome in Han Chinese women. Per Med, 2017, 14(4): 299-307

[13] StagiS, RicciF, BianconiM, et al.. Retrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome. Nutrients, 2017, 9(5): E524

[14] MoroF, MorcianoA, TropeaA, et al.. Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial. Reprod Sci, 2013, 20(12): 1508-1517

[15] BroekmansFJ, KnauffEA, ValkenburgO, et al.. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG, 2006, 113(10): 1210-1217

[16] CookH, BrennanK, AzzizR. Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism?. Fertil Steril, 2011, 96(5): 1266-1270

[17] MajidH, MasoodQ, KhanAH. Homeostatic Model Assessment for Insulin Resistance (HOMA-IR): A Better Marker for Evaluating Insulin Resistance Than Fasting Insulin in Women with Polycystic Ovarian Syndrome. J Coll Physicians Surg Pak, 2017, 27(3): 123-126

[18] LiuW, ZengQ, ChenY, et al.. Role of Leptin/Osteopontin Axis in the Function of Eosinophils in Allergic Rhinitis with Obesity. Mediators Inflamm, 2018, 2018: 9138904

[19] FriedmanJM. Leptin, leptin receptors, and the control of body weight. Nutr Rev, 1998, 56(2Pt2): s38-46

[20] EganOK, InglisMA, AndersonGM. Leptin Signaling in AgRP Neurons Modulates Puberty Onset and Adult Fertility in Mice. J Neurosci, 2017, 37(14): 3875-3886

[21] AlmogB, AzemF, KapustianskyR, et al.. Intrafollicular and serum levels of leptin during in vitro fertilization cycles: comparison between the effects of recombinant follicle-stimulating hormones and human menopausal gonadotrophin. Gynecol Endocrinol, 2011, 27(9): 666-668

[22] GoumenouAG, MatalliotakisIM, KoumantakisGE, et al.. The role of leptin in fertility. Eur J Obstet Gynecol Reprod Biol, 2003, 106(2): 118-124

[23] VazquezMJ, Romero-RuizA, Tena-SempereM. Roles of leptin in reproduction, pregnancy and polycystic ovary syndrome: consensus knowledge and recent developments. Metabolism, 2015, 64(1): 79-91

[24] ChanJL, BluherS, YiannakourisN, et al.. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes, 2002, 51(7): 2105-2112

[25] LeonhardtW, HornR, BrabantG, et al.. Relation of free and specifically bound leptin to insulin secretion in patients with impaired glucose tolerance (IGT). Exp Clin Endocrinol Diabetes, 1999, 107(1): 46-52

[26] RaffaelliM, IaconelliA, NanniG, et al.. Effects of biliopancreatic diversion on diurnal leptin, insulin and free fatty acid levels. Br J Surg, 2015, 102(6): 682-690

[27] OgawaT, HiroseH, YamamotoY, et al.. Relationships between serum soluble leptin receptor level and serum leptin and adiponectin levels, insulin resistance index, lipid profile, and leptin receptor gene polymorphisms in the Japanese population. Metabolism, 2004, 53(7): 879-885

[28] ShimizuH, ShimomuraK, NegishiM, et al.. Circulating concentrations of soluble leptin receptor: influence of menstrual cycle and diet therapy. Nutrition, 2002, 18(4): 309-312

[29] MorleyLC, TangT, YasminE, et al.. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev, 2017, 11: Cd003053

[30] SivalingamVN, MyersJ, NicholasS, et al.. Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications. Hum Reprod Update, 2014, 20(6): 853-868

[31] LogieL, LeesZ, AllwoodJW, et al.. Regulation of hepatic glucose production and AMPK by AICAR but not by metformin depends on drug uptake through the equilibrative nucleoside transporter 1 (ENT1). Diabetes Obes Metab, 2018, 20(12): 2748-2758